Tezepelumab for Severe Asthma: One Drug Targeting Multiple Disease Pathways and Patient Types
Reynold Panettieri Jr,1 Njira Lugogo,2 Jonathan Corren,3 Christopher S Ambrose4 1Rutgers Institute for Translational Medicine and Science, Rutgers University, New Brunswick, NJ, USA; 2Michigan Medicine Asthma Program, University of Michigan, Ann Arbor, MI, USA; 3Departments of Medicine and Pediatric...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2024-03-01
|
Series: | Journal of Asthma and Allergy |
Subjects: | |
Online Access: | https://www.dovepress.com/tezepelumab-for-severe-asthma-one-drug-targeting-multiple-disease-path-peer-reviewed-fulltext-article-JAA |